openPR Logo
Press release

Anti-Snoring Devices and Snoring Surgery Market opportunity rises to US$22.7 Billion by 2024

09-07-2017 11:52 AM CET | Health & Medicine

Press release from: TMR - Research Reports

Anti-Snoring Devices and Snoring Surgery Market opportunity

A slew of recent acquisitions have enabled Medtronic to emerge as the largest revenue contributor when it comes to anti-snoring devices. The top three companies in the global anti-snoring devices and snoring surgery market – namely Medtronic, GE Healthcare and Philips Healthcare, contribute a whopping 93.69% to the entire revenue pie. TMR has observed that a surge in R&D activities has strengthened the position of these companies in the global anti-snoring devices and snoring surgery market.

The presence of an increasing number of companies manufacturing and selling anti-snoring devices today has rendered the competitive landscape of the anti-snoring devices and snoring surgery market extremely fragmented, Transparency Market Research (TMR) finds. GE Healthcare, Philips Healthcare, Fisher & Paykel Healthcare, Medtronic plc, and ResMed, Inc. are not only the prominent players in the global anti-snoring devices and snoring surgery market but also account for a significant percentage share of the overall market. Although SomnoMed does not account for a major share in terms of percentage, its extensive product portfolio and robust market presence makes it a strong contender in the anti-snoring devices and snoring surgery market.

View Full Report: http://www.transparencymarketresearch.com/antisnoring-devices-and-snoring-surgery-market.html

Demand for low-cost and connected devices will gain speed

“The introduction of innovative devices is just as vital in gaining a competitive edge,” says a TMR analyst. “Anti-snoring device companies have been increasingly focused on improving the performance of existing products. The miniaturization of sleep apnea devices is a recent trend driven by the integration of nanotechnology.

The demand for compact and low-cost devices has provided vendors a major opportunity. Case in point, Airing LLC. The medical device company launched a revolutionary disposable, battery-operated, and cordless micro-continuous positive airway pressure (CPAP) device in May 2015.

Request to view Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=6910

The large-scale proliferation of the Internet of Things (IoT) has penetrated the medical devices sector as well. The growing demand for connected and wireless devices as well as remote patient monitoring is reflected in the way an increasing number of anti-snoring devices companies are integrating IoT with their products. Medco Health is one such company. In February 2015, the medical device maker launched an innovative telemedicine assistance system that not only monitors the sleeping patterns of patients with obstructive sleep apnea disorder but also helps schedule doctors’ appointments.

It has been observed that leading vendors have also been investing significant resources in enhancing the performance of anti-snoring devices to drive the acceptance and sales of anti-snoring devices.

Companies will need to overcome lack of patient compliance to spur sales

The demand for anti-snoring devices and snoring surgery is being driven by a number of physiological factors. A surge in the incidence of obstructive sleep apnea, an increase in the number of people suffering from sleep deprivation and snoring, and an alarming prevalence of obesity have considerably fueled the need for anti-snoring devices. “People with obesity are four times more likely to snore compared to those of normal weight,” states TMR based on its findings.

Request to download and view full ToC - http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=6910

The development of state-of-the-art technologies by market players and a focus on extensive marketing have also enhanced the uptake of anti-snoring devices.

In contrast, a lack of patient compliance, certain side effects such as throat dryness and nasal congestion, ambiguity in handling the device have limited the use of anti-snoring devices among patients. The high price of these devices is also a major factor dampening the sales of the devices.

Competitive pricing of devices is likely to curb high revenue growth

The global market for anti-snoring devices and snoring surgery is projected to expand at a steady 3.9% CAGR from 2016 to 2024, with the market opportunity rising from US$16 bn in 2015 to US$22.7 bn by 2024. Continuous positive airway pressure (CPAP) devices rake in the highest revenue in terms of device. The opportunity of this device segment is forecast to increase from US$12.1 bn in 2015 to US$16.4 bn by 2024.

On the other hand, tongue stabilizing devices (TSDs) are likely to witness the highest growth, with sales rising from 32.81 mn units in 2015 to 51.54 mn units by the end of 2024. However, TMR states that the competitive pricing of these devices limits revenue growth.

Global Anti-Snoring Devices and Snoring Surgery Market Report is available @ US$ 5795: http://www.transparencymarketresearch.com/checkout.php?rep_id=6910<ype=S

About TMR

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anti-Snoring Devices and Snoring Surgery Market opportunity rises to US$22.7 Billion by 2024 here

News-ID: 702798 • Views: 181

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Snoring

Anti-Snoring Devices and Snoring Surgery Market 2018 – 2026 | Leading Manufact …
Snoring is a common sleeping condition caused owing to the airway blockage. Snoring is a symptom or indication of obstructive sleep apnea. The airway block is originated from various causes such as tonsil enlargement, nasal congestion, or improper mouth anatomical structure, which narrow down the passageway of air flow and breathing gets more or less clogged. In addition, usage of sedatives or antidepressant drugs, alcohol consumption, obesity, smoking, and allergies
Anti-Snoring Treatment Market
Snoring is the vibration of respiratory structures which results in sound while sleeping. It is a sleeping disorder caused due to monotonous narrowing and collapsing of the upper airway. Snoring have various adverse effects on health include coronary artery disease, systemic hypertension, atrial fibrillation, and stroke. Snoring is one of the factors of sleep deprivation, which may be further caused due to throat weakness, mis-positioned jaw, obesity, and obstruction in
Anti-Snoring Devices and Snoring Surgery Market Foreseen To Grow Exponentially O …
The Global Anti-Snoring Devices And Snoring Surgery Market is extremely fragmented and is competitive in nature, states Transparency Market Research (TMR) in its new report on this market. Some of the leading players within this market are: Philips Healthcare, GE Healthcare, Fisher & Paykel Healthcare, ResMed, Inc., and Medtronic plc. Of these, Medtronic has emerged as the largest contributor in terms of revenue on account of the company’s several recent
Anti-Snoring Devices and Snoring Surgery Market Industry Analysis, Opportunity A …
According to the TMR report, the global market for anti-snoring devices and snoring surgery is projected to be worth US$22.7 bn by 2024. On the basis of type of device, the market for Continuous positive airway pressure (CPAP) devices will lead and is estimated to be worth US$16.4 bn by 2024. However, highest growth will be witnessed by the tongue stabilizing devices (TSDs) segment. View and Download TOC of Anti-Snoring
Anti-Snoring Devices and Snoring Surgery Market Research Report by Geographical …
The report analyzes the global market for anti-snoring devices and snoring surgery based on three major segments: device type, surgical procedure, and geography. Based on device type, the market has been categorized into four major diagnostic devices: mandibular advancement devices (MAD), tongue stabilizing device (TSD), continuous positive airway pressure (CPAP) devices, and others (nasal strip, chain straps, rings). Based on surgical procedure, the market has been segmented into uvulopalatopharyngoplasty (UPPP)
Asia Pacific Anti-snoring Devices and Snoring Surgery Market grows with increase …
The presence of an increasing number of companies manufacturing and selling anti-snoring devices today has rendered the competitive landscape of the anti-snoring devices and snoring surgery market extremely fragmented, Transparency Market Research (TMR) finds. GE Healthcare, Philips Healthcare, Fisher & Paykel Healthcare, Medtronic plc, and ResMed, Inc. are not only the prominent players in the global anti-snoring devices and snoring surgery market but also account for a significant percentage share